These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1614071)

  • 1. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M
    Kidney Int Suppl; 1992 May; 36():S66-72. PubMed ID: 1614071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem and renal hemodynamics: implications for renal protection.
    Epstein M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S21-5. PubMed ID: 1725538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium antagonists on renal hemodynamics.
    Epstein M; Loutzenhiser RD
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):10-4. PubMed ID: 2220795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and renal hemodynamics: implications for renal protection.
    Epstein M
    Clin Invest Med; 1991 Dec; 14(6):590-5. PubMed ID: 1794210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):251S-259S. PubMed ID: 8398009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):482S-486S. PubMed ID: 1910641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and renal hemodynamics: implications for renal protection.
    Epstein M
    J Am Soc Nephrol; 1991 Aug; 2(2 Suppl 1):S30-6. PubMed ID: 1932641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and the kidney.
    Loutzenhiser RD; Epstein M
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):154S-161S. PubMed ID: 2665786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists and the kidney.
    Epstein M; Loutzenhiser RD
    Tohoku J Exp Med; 1992 Jan; 166(1):123-34. PubMed ID: 1412439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M; Hayashi K
    Am J Cardiol; 1989 Sep; 64(11):41F-45F. PubMed ID: 2782270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal microvascular actions of calcium antagonists.
    Loutzenhiser R; Epstein M
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S48-52. PubMed ID: 2468906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal protective effects of calcium antagonists].
    Musialik D; Raszeja-Wanic B; Tylarski A
    Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M; Horton C
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S70-5. PubMed ID: 2441189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.